Liposomal Vitamin K2

Liposomal Vitamin K2 (menaquinone-7, MK-7) encapsulates the fat-soluble cofactor within phospholipid bilayers forming unilamellar vesicles, via thin-film hydration or ethanol injection.

This biomimetic delivery shields against enzymatic degradation, boosting intestinal absorption 5-10x over free forms through endocytosis and membrane fusion, enhancing osteocalcin carboxylation for bone and vascular integrity.

Key Features:

• Liposomal delivery boosts bioavailability up to 5-10x, ensuring more K2 reaches cells for optimal function vs. standard forms.
• Activates osteocalcin to direct calcium to bones, reducing osteoporosis risk and supporting density.
• Prevents arterial calcification via matrix GLA protein, lowering cardiovascular disease risk.
• Aids coagulation and may regulate blood pressure for vascular health.
• Enhances with D3 for immunity, muscle function, and overall calcium balance.

Technical & Regulatory Strengths:

• All liposomal minerals and vitamins are supported by whitepapers containing complete characterisation data, prepared in accordance with USFDA guidelines.
• In vitro study compliance has been established.
• The formulations demonstrate the highest encapsulation efficiency.
• Three (3) years of stability studies have been performed, confirming long-term product stability.